Institute Gustave-Roussy (IGR)
Gustave Roussy (IGR)
France
1 November 2019 - 31 October 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Institute Gustave-Roussy (IGR) published between 1 November 2019 - 31 October 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
66 | 5.82 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 61 | 5.64 | |
Chemistry | 4 | 0.17 | |
Physical Sciences | 2 | 0.06 |
Top articles by Altmetric score in current window
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics
2020-01-07
1 November 2019 - 31 October 2020
International vs. domestic collaboration by Share
- 70.17% Domestic
- 29.83% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (245 total)
- Institute Gustave-Roussy (IGR), France
- Domestic institution
-
National Institute for Health and Medical Research (INSERM), France
(10.70)
-
French National Centre for Scientific Research (CNRS), France
(9.46)
-
University of Paris-Sud (UPSud), France
(7.72)
-
University of Paris, France
(5.39)
-
Assistance Publique-Hôpitaux de Paris (AP-HP), France
(4.73)
-
Curie Institute, France
(4.59)
-
Sorbonne University, France
(3.48)
-
Ligue Contre Le Cancer, France
(3.24)
-
University of Paris-Saclay, France
(2.95)
-
Institut Mines-Télécom (IMT), France
(2.67)
Top 10 international collaborators by Share (868 total)
- Institute Gustave-Roussy (IGR), France
- Foreign institution
-
Karolinska Institute (KI), Sweden
(1.92)
-
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), China
(1.87)
-
The University of Texas MD Anderson Cancer Center, United States of America (USA)
(1.69)
-
Harvard University, United States of America (USA)
(1.68)
-
National Institutes of Health (NIH), United States of America (USA)
(1.48)
-
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Italy
(1.09)
-
F. Hoffmann-La Roche AG, Switzerland
(0.89)
-
Cornell University, United States of America (USA)
(0.83)
-
Czech Academy of Sciences (CAS), Czech Republic
(0.77)
-
Northwestern University (NU), United States of America (USA)
(0.73)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Affiliated joint institutions and consortia
- Unité Intégrité du Génome et Cancers, France
- Génomique Cellulaire des Cancers, France
- Microenvironnement des Niches Tumorales (MicroNiT), France
- Analyse Moléculaire, Modélisation et Imagerie de la Maladie Cancéreuse (AMMICA), France
- Unité Physiologie et Pathologie Moléculaires des Rétrovirus Endogènes et Infectieux, France
- Cellules Souches Hématopoïétiques et Développement des Hémopathies Myéloïdes, France
- Radiothérapie Moléculaire, France
- Profils Tanscriptionnels dans les Myelofibroses, France
- Nutrition, Hormones et Cancers, France
- Génétique Oncologique, France
- Hématopoïèse et Cellules Souches, France
- CNRS Génétique Oncologique, France
- Stabilité Génétique et Oncogenèse, France
- Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses, France
- Institut de Recherche Intégrée en Cancérologie à Villejuif (IRCIV), France
- Rétrovirus Endogènes et Eléments Rétroïdes des Eucaryotes Supérieurs, France
- Apoptosis Cancer and Immunity, France
- Center of Clinical Investigations, France
- Center of Clinical Investigations in Biotherapies of Cancer (CICBT), France
- Centre de Biothérapie, France
- Cordelier Research Center (CRC), France
- Genetic of Tumors, France
- INCa-ICGC Breast Cancer Consortium, France
- Integrative Tumor Immunology and Genetic Oncology, France
- LabEx LERMIT, France
- LabEx LipSTIC, France
- Laboratory for Immunomonitoring in Oncology (LIO), France
- Predictive Biomarkers and Novel Therapeutic Strategies in Oncology, France
- Signalisation, Rho GTPases et progression tumorale, France
- Signalling, Nuclei and Innovations in Oncology, France
- Tobacco and Genetics Consortium (TAG), United States of America (USA)
- Tumour Immunology and Anti-Cancer Immunotherapy Unit, France
- Tumour Immunology and Immunotherapy, France

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.